Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity, US-based manufacturing, and high scale-up success rate are helping industry customers meet product milestones in 2024 and beyond.

View the video below to hear from Rose Rhomberg, Senior Business Development Director,  about our 20+ years of experience and current microbial and mammalian capabilities.